270 related articles for article (PubMed ID: 8032575)
1. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
Götz J; Sauter R; Steinijans VW; Jonkman JH
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
Steinijans VW; Sauter R; Böhm A; Staudinger H
Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
[TBL] [Abstract][Full Text] [Related]
3. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
[TBL] [Abstract][Full Text] [Related]
6. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger HW; Sauter R; Steinijans VW
Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
[TBL] [Abstract][Full Text] [Related]
7. Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration.
Steinijans VW; Trautmann H; Sauter R; Staudinger H
Arzneimittelforschung; 1988 Aug; 38(8A):1251-3. PubMed ID: 3190814
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
[TBL] [Abstract][Full Text] [Related]
9. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
10. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetics of two sustained-release theophylline products during once-daily and twice-daily dosing.
Armstrong EP; Nako N; Plezia PM; Kramer TH; Jones WN
Clin Pharm; 1987 Oct; 6(10):800-4. PubMed ID: 3505842
[No Abstract] [Full Text] [Related]
12. [Comparison of the bioavailability and pharmacokinetic profile of a theophylline pellet formulation designed for once-daily dosage with a pellet preparation designed for twice-daily dosage].
Keinke O
Arzneimittelforschung; 1989 Nov; 39(11):1460-4. PubMed ID: 2619780
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
14. Serum theophylline profile with once-daily theophylline (Uniphyl) following conversion from intravenous theophylline in adult asthmatic patients.
Fradette M; Babich M; Friesen EG; Archibald JS; Babul N
Clin Ther; 1994; 16(2):160-8. PubMed ID: 8062311
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
Trnavská Z; Vondra V; Elis J
Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
[TBL] [Abstract][Full Text] [Related]
16. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
17. Night-time pharmacokinetics of once a day theophylline: a steady state comparison of three preparations.
Karttunen P; Tukiainen H; Nykänen S; Saano V
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):161-5. PubMed ID: 3997302
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
Langston VC; Koritz GD; Davis LE; Neff-Davis C
Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
[TBL] [Abstract][Full Text] [Related]
19. Effect of drug intake prior to or after meals on serum theophylline concentrations: single-dose studies with Euphylong.
Schulz HU; Karlsson S; Sahner-Ahrens I; Steinijans VW; Beier W
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):222-8. PubMed ID: 3583472
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel does not affect the pharmacokinetics of theophylline.
Caplain H; Thebault JJ; Necciari J
Semin Thromb Hemost; 1999; 25 Suppl 2():65-8. PubMed ID: 10440427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
